Friday, March 13, 2009

Is Roche Buying Genentech's Ills?

Roche's $46.8 billion acquisition makes sense at first. But insurers may balk at covering some of Genentech's expensive new cancer drugs. ... http://link.gs/aLPU
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)